CLINICAL AND ECONOMIC OUTCOMES OF LATANOPROST BIMATOPROST OR TRAVOPROST THERAPY IN GLAUCOMA PATIENTS: A THREE-MONTH RETRO-SPECTIVE STUDY

被引：0
|
作者：
G.F.Schwartz
C.P.Schaefer
Y.C.Yeh
J.Nordin
E.Mozaffari
机构：
[1] Baltimore Medical Center
[2] Covance Health Eco-nomics and Outcomes Services Inc.
[3] Glaucoma Consultants Greater
[4] Johns Hopkins and The University of Maryland
[5] MD
[6] NJ
[7] Pharmacia Corpo-ration
[8] USA
[9] Wilmer Eye Institute
来源：
国际眼科杂志 | 2003年 / 01期
关键词：
or; A THREE-MONTH RETRO-SPECTIVE STUDY; CLINICAL AND ECONOMIC OUTCOMES OF LATANOPROST BIMATOPROST OR TRAVOPROST THERAPY IN GLAUCOMA PATIENTS; in; with; from; IOP; were;
D O I：
暂无
中图分类号：
R775 [眼压与青光眼];
学科分类号：
100212 ;
摘要：
Purpose: To evaluate rates of hyperemia in patients treated with latanoprost, bimatoprost, or travoprost and to compare groups in IOP response and costs. Methods: This 3-month, retrospective, multicenter, non-randomized, medical chart review included patients from 10 U.S. sites, who either initiated or changed to latanoprost, bimatoprost, or travoprost for the treatment of primary open-angle glaucoma or ocular hypertension after January 1, 2001. Patients had follow-up data for at least 3 months fol-
引用
收藏
页码：87 / 88
页数：2
相关论文
共 50 条
12345